Related Experiment Video
Updated: May 6, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Delivery of RNAi therapeutics: work in progress
1Institute of Pharmaceutical Science, King's College London, Franklin-Wilkins Building, Waterloo Campus, 150 Stamford Street, London SE1 9NH , UK and GlobalAcorn Limited , London , UK a.miller07@btinternet.com andrew.miller@globalacorn.com.
Lipid-based nanoparticles (LNPs) are crucial for delivering RNA interference (RNAi) therapeutics to target cells in vivo. Research is advancing LNP systems for improved RNAi therapy efficacy and clinical viability.
Area of Science:
- Biotechnology
- Nanomedicine
- Molecular Biology
Background:
- RNA interference (RNAi) therapeutics hold significant promise for future medical treatments.
- Effective delivery of RNAi effectors to target cells in vivo remains a critical challenge, often requiring specialized delivery systems or vectors.
Purpose of the Study:
- This review focuses on lipid-based nanoparticle (LNP) delivery systems for RNAi effectors.
- It examines LNPs that have demonstrated effective in vivo delivery of functional RNAi payloads to target cells.
Main Methods:
- The review synthesizes current research and development in LNP delivery systems for RNAi.
- It analyzes studies investigating LNP-mediated delivery in vivo and the biophysical and chemical principles governing their behavior.
Main Results:
- LNPs are emerging as preferred synthetic delivery systems in preclinical studies and clinical trials for RNAi effectors.
- Studies are identifying key biophysical parameters and physical organic chemistry rules for understanding LNP delivery in vivo.
Conclusions:
- LNP delivery systems are rapidly growing in utility for RNAi therapeutics.
- The identified parameters and rules provide a foundation for developing next-generation LNPs with enhanced clinical viability.
Related Concept Videos
Experimental RNAi
RNA Interference
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Types of RNA
RNA Performs Diverse...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

